Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

196
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
196

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Latent Class Analysis to Identify Phenotype-Specific Treatment Effects of Catheter Ablation Versus Drug Therapy in Patients with Atrial Fibrillation: A Secondary Analysis of the CABANA Trial.

Heart rhythm·2026
Same author

Early recurrence of atrial tachyarrhythmia after catheter ablation and its associations with clinical outcomes, atrial fibrillation burden, and blanking period duration: A post hoc analysis of the CABANA trial.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Predictors of pacing-induced cardiomyopathy in patients undergoing AV nodal ablation: insights from a Delphi process and retrospective cohort study.

European heart journal open·2026
Same author

Patient-Reported Outcome Measures Following Pulsed-Field Ablation Versus Thermal Ablation of Atrial Fibrillation: The PROMs-PFA Study.

Journal of cardiovascular electrophysiology·2026
Same author

Beyond the Triple-Negative Label: A Case Report on Metaplastic Breast Carcinoma.

Clinical case reports·2026
Same author

Transseptal puncture in cardiovascular interventions: a clinical consensus statement of the European Heart Rhythm Association, the Heart Failure Association, the European Association of Percutaneous Cardiovascular Interventions, the European Association of Cardiovascular Imaging of the ESC, and the Association for European Paediatric and Congenital Cardiology.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026

Related Experiment Video

Updated: Dec 13, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K

Left Atrial Appendage Occlusion: Past, Present and Future.

Wern Yew Ding1,2, John Mandrola3, Dhiraj Gupta1,2

  • 1Liverpool Centre for Cardiovascular Science, Department of Cardiology, University of Liverpool, Liverpool, United Kingdom.

Thrombosis and Haemostasis
|July 28, 2020
PubMed
Summary

Left atrial appendage (LAA) occlusion is a promising alternative to oral anticoagulation for stroke prevention in atrial fibrillation (AF) patients unsuitable for blood thinners. More research is needed to confirm its long-term effectiveness and cost-efficiency.

More Related Videos

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.1K

Related Experiment Videos

Last Updated: Dec 13, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.8K
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.2K
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

4.1K

Area of Science:

  • Cardiology
  • Medical Devices
  • Interventional Procedures

Background:

  • Oral anticoagulation is often unsuitable for stroke prevention in atrial fibrillation (AF) patients.
  • Percutaneous left atrial appendage (LAA) occlusion has emerged as a significant alternative.
  • Existing data suggest favorable outcomes, leading to guideline recommendations for specific patient groups.

Purpose of the Study:

  • To evaluate the role and efficacy of LAA occlusion in AF patients.
  • To address the lack of prospective controlled trials for LAA occlusion.
  • To investigate the cost-effectiveness of LAA occlusion in high-risk patient populations.

Main Methods:

  • Review of registry and cohort study data on LAA occlusion outcomes.
  • Analysis of existing cost-effectiveness modeling studies.
  • Identification of research gaps, particularly in prospective trials and high-risk patient cohorts.

Main Results:

  • Registries and cohort studies show favorable short- and long-term outcomes for LAA occlusion.
  • International guidelines recommend LAA occlusion for AF patients with contraindications to oral anticoagulation.
  • Prospective controlled trials are currently lacking in this population.

Conclusions:

  • LAA occlusion is a promising strategy for stroke prevention in AF patients with contraindications to oral anticoagulation.
  • Further research, including prospective trials, is essential to define its exact role and long-term efficacy.
  • Cost-effectiveness needs further investigation, especially in high-risk patients with limited long-term survival.